Stay updated on Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial

Sign up to get notified when there's something new on the Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A site-wide NIH notice was added announcing updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    1%
    Check dated 2026-10-24T15:47:26.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T15:39:43.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The site footer revision indicator changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-10T15:35:05.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study record details, indicating access restrictions to the content; the UI displays an error message and a 403 header.
    Difference
    20%
    Check dated 2026-09-19T19:17:04.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing v3.6.5, indicating a new page revision that reflects backend or formatting updates rather than changes to the study information.
    Difference
    0.1%
    Check dated 2026-08-29T13:01:44.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page now displays the full Study Details content for the trial, including design, eligibility, outcomes, locations, and collaborators, replacing the previous error page. This re-establishes access to essential information about the study.
    Difference
    57%
    Check dated 2026-08-15T02:49:32.000Z thumbnail image

Stay in the know with updates to Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial page.